Related references
Note: Only part of the references are listed.Fitness Tradeoffs of Antibiotic Resistance in Extraintestinal Pathogenic Escherichia coli
Prabh Basra et al.
GENOME BIOLOGY AND EVOLUTION (2018)
UniProt: the universal protein knowledgebase
Alex Bateman et al.
NUCLEIC ACIDS RESEARCH (2017)
The Pfam protein families database: towards a more sustainable future
Robert D. Finn et al.
NUCLEIC ACIDS RESEARCH (2016)
Collateral sensitivity of antibiotic-resistant microbes
Csaba Pal et al.
TRENDS IN MICROBIOLOGY (2015)
The genetic basis of the fitness costs of antimicrobial resistance: a meta-analysis approach
Tom Vogwill et al.
EVOLUTIONARY APPLICATIONS (2015)
The fitness costs of antibiotic resistance mutations
Anita H. Melnyk et al.
EVOLUTIONARY APPLICATIONS (2015)
Trimmomatic: a flexible trimmer for Illumina sequence data
Anthony M. Bolger et al.
BIOINFORMATICS (2014)
The mechanism of negative DNA supercoiling: A cascade of DNA-induced conformational changes prepares gyrase for strand passage
Airat Gubaev et al.
DNA REPAIR (2014)
Growth Rates Made Easy
Barry G. Hall et al.
MOLECULAR BIOLOGY AND EVOLUTION (2014)
Structure of the N-Terminal Gyrase B Fragment in Complex with ADP•Pi Reveals Rigid-Body Motion Induced by ATP Hydrolysis
Frederic V. Stanger et al.
PLOS ONE (2014)
Determinants of quinolone resistance in Escherichia coli causing community-acquired urinary tract infection in Bejaia, Algeria
Yanat Betitra et al.
ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE (2014)
Seven Ways to Preserve the Miracle of Antibiotics
John G. Bartlett et al.
CLINICAL INFECTIOUS DISEASES (2013)
Antibiotics in crisis
Michael Gross
CURRENT BIOLOGY (2013)
Bacterial evolution of antibiotic hypersensitivity
Viktoria Lazar et al.
MOLECULAR SYSTEMS BIOLOGY (2013)
Use of Collateral Sensitivity Networks to Design Drug Cycling Protocols That Avoid Resistance Development
Lejla Imamovic et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
New antibiotic agents in the pipeline and how they can help overcome microbial resistance
Ian M. Gould et al.
VIRULENCE (2013)
A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3
Pablo Cingolani et al.
FLY (2012)
The crisis of no new antibiotics-what is the way forward?
Laura J. V. Piddock
LANCET INFECTIOUS DISEASES (2012)
Evolutionary paths to antibiotic resistance under dynamically sustained drug selection
Erdal Toprak et al.
NATURE GENETICS (2012)
Harnessing recombination to speed adaptive evolution in Escherichia coli
James Winkler et al.
METABOLIC ENGINEERING (2012)
Genomics of Adaptation during Experimental Evolution of the Opportunistic Pathogen Pseudomonas aeruginosa
Alex Wong et al.
PLOS GENETICS (2012)
Synthesis of lipophilic dimeric C-7/C-7-linked ciprofloxacin and C-6/C-6-linked levofloxacin derivatives. Versatile in vitro biological evaluations of monomeric and dimeric fluoroquinolone derivatives as potential antitumor, antibacterial or antimycobacterial agents
Joelle Azema et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
The Fitness Cost of Rifampicin Resistance in Pseudomonas aeruginosa Depends on Demand for RNA Polymerase
Alex R. Hall et al.
GENETICS (2011)
In front of and behind the replication fork: bacterial type IIA topoisomerases
Claudia Sissi et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates
Dong Chan Moon et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Antibiotic resistance and its cost: is it possible to reverse resistance?
Dan I. Andersson et al.
NATURE REVIEWS MICROBIOLOGY (2010)
Relationships among Ciprofloxacin, Gatifloxacin, Levofloxacin, and Norfloxacin MICs for Fluoroquinolone-Resistant Escherichia coli Clinical Isolates
Lauren Becnel Boyd et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Mechanisms Accounting for Fluoroquinolone Resistance in Escherichia coli Clinical Isolates
Sonia K. Morgan-Linnell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Fluctuation AnaLysis CalculatOR: a web tool for the determination of mutation rate using Luria-Delbruck fluctuation analysis
Brandon M. Hall et al.
BIOINFORMATICS (2009)
The Sequence Alignment/Map format and SAMtools
Heng Li et al.
BIOINFORMATICS (2009)
Interplay in the Selection of Fluoroquinolone Resistance and Bacterial Fitness
Linda L. Marcusson et al.
PLOS PATHOGENS (2009)
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome
Ben Langmead et al.
GENOME BIOLOGY (2009)
Contributions of the combined effects of topoisomerase mutations toward fluoroquinolone resistance in Escherichia coli
Sonia K. Morgan-Linnell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Fitness costs of fluoroquinolone resistance in Streptococcus pneumoniae
Daniel E. Rozen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
The competitive cost of antibiotic resistance in Mycobacterium tuberculosis
Sebastien Gagneux et al.
SCIENCE (2006)
Mechanisms of antimicrobial resistance in bacteria
Fred C. Tenover
AMERICAN JOURNAL OF INFECTION CONTROL (2006)
Fitness of antimicrobial-resistant Campylobacter and Salmonella
Qijing Zhang et al.
MICROBES AND INFECTION (2006)
Influence of efflux transporters on the accumulation and efflux of four quinolones (ciprofloxacin, levofloxacin, garenoxacin, and moxifloxacin) in J774 macrophages
JM Michot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Biological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections
PK Lindgren et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Mechanisms of quinolone resistance in Escherichia coli and Salmonella:: Recent developments
KL Hopkins et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Enhanced in vivo fitness of fluoroquinolone-resistant Campylobacter jejuni in the absence of antibiotic selection pressure
ND Luo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Reduction of the fitness burden of quinolone resistance in Pseudomonas aeruginosa
E Kugelberg et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
The speed of adaptation in large asexual populations
CO Wilke
GENETICS (2004)
Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections
PK Lindgren et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection
J Ruiz
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Development of the quinolones
MI Andersson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
DNA gyrase and topoisomerase IV mutations associated with fluoroquinolone resistance in Proteus mirabilis
LM Weigel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Quinolone-binding pocket of DNA gyrase: Role of GyrB
J Heddle et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
The multiple antibiotic resistance (mar) locus and its significance
LP Randall et al.
RESEARCH IN VETERINARY SCIENCE (2002)
Restricting the selection of antibiotic-resistant mutants: A general strategy derived from fluoroquinolone studies
XL Zhao et al.
CLINICAL INFECTIOUS DISEASES (2001)
Quinolone molecular structure-activity relationships: What we have learned about improving antimicrobial activity
LR Peterson
CLINICAL INFECTIOUS DISEASES (2001)
Mutation in the DNA gyrase A gene of Escherichia coli that expands the quinolone resistance-determining region
SM Friedman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
The crystal structure of MarR, a regulator of multiple antibiotic resistance, at 2.3 Å resolution
MN Alekshun et al.
NATURE STRUCTURAL BIOLOGY (2001)
Interaction between DNA gyrase and quinolones:: Effects of alanine mutations at GyrA subunit residues Ser83 and Asp87
FM Barnard et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Mechanisms responsible for cross-resistance and dichotomous resistance among the quinolones
CC Sanders
CLINICAL INFECTIOUS DISEASES (2001)
Intracellular targets of moxifloxacin: a comparison with other fluoroquinolones
E Pestova et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Mutational analysis of MarR, the negative regulator of marRAB expression in Escherichia coli, suggests the presence of two regions required for DNA binding
MN Alekshun et al.
MOLECULAR MICROBIOLOGY (2000)
Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance
J Björkman et al.
SCIENCE (2000)
Dimerization of Escherichia coli DNA-gyrase B provides a structural mechanism for activating the ATPase catalytic center
L Brino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Determining mutation rates in bacterial populations
WA Rosche et al.
METHODS-A COMPANION TO METHODS IN ENZYMOLOGY (2000)
Share Paper
